Quantcast

Latest CytoSorbents Corporation Stories

2014-07-17 08:25:12

MONMOUTH JUNCTION, N.J., July 17, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber in multiple countries worldwide, announced the PDF availability of the first publication describing the use of CytoSorb® intra-operatively during cardiac surgery at the Ludwig Maximilian University of Munich Hospital - Grosshadern Campus, in Germany....

2014-07-09 08:28:26

MONMOUTH JUNCTION, N.J., July 9, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses, announced consolidation of its SEC and international legal counsel with the global law firm, DLA Piper LLP. DLA Piper is one of the largest international business law firms with offices in major markets around the world and legal expertise across a broad range of areas including corporate and...

2014-05-14 16:28:19

MONMOUTH JUNCTION, N.J., May 14, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCBB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses, reports first quarter operational and financial results for the three months ended March 31, 2014. http://photos.prnewswire.com/prnvar/20140408/MM00899LOGO Achieved record total revenue and CytoSorb® sales of $1.1M and $569,000, respectively, in Q1 2014 with continued strong momentum expected in Q2...

2014-05-08 08:31:33

MONMOUTH JUNCTION, N.J., May 8, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood filter to treat life-threatening illnesses in the intensive care unit, will report Q1 2014 financial results after the market close on Wednesday, May 14, 2014. http://photos.prnewswire.com/prnvar/20140408/MM00899LOGO CytoSorbents' management will host a live conference call and presentation...

2014-04-03 08:30:31

MONMOUTH JUNCTION, N.J., April 3, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life threatening conditions in the intensive care unit, announced that Dr. Phillip Chan, MD, PhD, Chief Executive Officer of CytoSorbents, will present a corporate overview at the 13(th) Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York City, New York. Dr. Chan will present from 10:00...

2014-03-31 16:27:14

MONMOUTH JUNCTION, N.J., March 31, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses in the intensive care unit, provides an operational summary and financial results for the fiscal year ending December 31, 2013. Q1 2014 CytoSorb® product revenue guidance in the range of $530,000 - $570,000 represents more than 60% of total 2013 CytoSorb® revenues Highlights for the Year Ending...

2014-03-25 08:28:57

MONMOUTH JUNCTION, N.J., March 25, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood filter to treat life-threatening illnesses in the intensive care unit, will report fiscal 2013 financial results after the market close on Monday, March 31, 2014. CytoSorbents' management will host a live conference call and presentation webcast that will recount both operational and...

2014-03-13 08:27:59

MONMOUTH JUNCTION, N.J., March 13, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses in the intensive care unit, announced that it will sponsor a research symposium entitled: "SIRS and SEPSIS - New Therapy with CytoSorb®" at the 34(th) International Symposium on Intensive Care and Emergency Medicine (ISICEM 2014) in Brussels, Belgium next week. The program is scheduled for...

2014-03-07 12:25:20

MONMOUTH JUNCTION, N.J., March 7, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCBB: CTSO), a Nevada corporation, today announced that it has entered into subscription agreements with certain institutional investors to sell approximately $10,200,000 of its common stock and warrants to purchase common stock in a registered direct offering. Under the terms of the subscription agreements, the Company will issue an aggregate of 40,800,000 shares of common stock at a price of $0.25 per...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related